Gaps in the ethical governance of pharmaceutical clinical trials in Europe
The ethical governance of pharmaceutical clinical trials in Europe, particularly under Regulation 536/2014, is intended to ensure the safety, rights, and well-being of participants. Despite this regulatory framework, significant gaps in ethical oversight remain. This paper identifies five key defici...
Saved in:
Main Authors: | Rosemarie D. L. C. Bernabe, Shereen A. Dawkins-Cox, Christine C. Gispen-de Wied |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1507021/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ethical aspects of clinical trials in Russia and BRICS countries: an overview
by: Sergey Y. Simeniv, et al.
Published: (2024-09-01) -
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
by: Breanne Stewart, et al.
Published: (2025-02-01) -
Theranos: the Ethics of Innovation and Deception in Healthcare Technology
by: Edgar Manuel Cambaza
Published: (2024-09-01) -
Evaluating cognitive bias in clinical ethics supports: a scoping review
by: Louise Giaume, et al.
Published: (2025-01-01) -
Contextual Vulnerability Should Guide Fair Subject Selection in Xenotransplantation Clinical Trials
by: Gianna Strand
Published: (2023-03-01)